Acer Therapeutics Inc. (ACER) Social Stream
Acer Therapeutics Inc (ACER) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering ACER.
|Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Current Price||Upside Potential|
Price Target Last Issued November 30, 2021
The Trend in the Analyst Price Target
ACER's average price target has moved down $0 over the prior 45 weeks.
Over the past 19 months, ACER's average upside potential has been 257.11%.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Share Price||Upside Potential|
ACER Broker Recommendations Summary
|Average Broker Rating||Strong Buy||Buy||Hold||Sell||Strong Sell||Analysts Issuing Recs|
The Trend in the Broker Recommendations
Over the past 61 days, ACER's average broker recommendation rating improved by 1.67.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for ACER as an investment opportunity.
- The variance in analysts' estimates of ACER is lower than nearly 100% of all US stocks.
- ACER has a greater number of analysts covering the stock than 5.61% of Pharmaceutical Products stocks.
- Acer Therapeutics Inc's upside potential (average analyst target price relative to current price) is higher than 190.3% of all US stocks.
- Acer Therapeutics Inc's average analyst price target is greater than 19.06% of all US stocks.
In the Pharmaceutical Products industry, ACOR, ATOS and MIRO are the three stocks most similar to Acer Therapeutics Inc regarding the price target and analyst recommendation information presented here.
What is the outlook for ACER? Use POWR Ratings for clearer insight into price direction.